Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT07056595
Eligibility Criteria:
Inclusion Criteria:
* Adults (\> 18 years) with the primary IgAN diagnosed by kidney biopsy;
* Treatment with stable doses of iRAS or/and iSGLT2 inhibitors for at least 3 months prior inclusion into the trial;
* Blood pressure \< 140/90 mm Hg
* 24-hour urinary albumin excretion \> 300 mg
Exclusion Criteria:
* Kidney transplantation in medical history
* Chronic hepatic disease, including hepatitis, malignant tumor, active malignancy;
* Heart failure with ejection fraction \<40%;
* Acute myocardial infarction and/or stroke less then 3 months before including in trial;
* Presence ANCA in serum
* Ongoing immunosuppressive treatment
* eGFR \< 20 ml/min
* Pregnancy and breastfeeding
* Uncontrolled blood pressure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07056595
Study Brief:
Protocol Section:
NCT07056595